nach oben

Current Breast Cancer Reports

Erschienen in:

01.06.2015 | Risk, Prevention, and Screening (TA Patel, Section Editor)

The Genetic Information Nondiscrimination Act of 2008 (GINA) and the Patient Protection and Affordable Care Act of 2010 (PPACA): What They Mean for Breast Cancer Patients and Their Families

verfasst von: Mary Beth Wilson Steck

Erschienen in: Current Breast Cancer Reports | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

From 2007 to 2011, deaths in females due to breast cancer declined in the USA. This decline has been attributed to improved access to breast cancer screening and subsequent effective treatments for female with invasive breast cancer. In this same time period, two federal health-care policies were enacted, the Genetic Information Nondiscrimination Act of 2008 (GINA), to decrease fear of discrimination based on genetic information (genetics tests results and/or family history) in health insurance and employment arenas, and the Patient Protection and Affordable Care Act of 2010 (PPACA), health-care reform to improve access for breast cancer screening. Health-care providers need to be knowledgeable about GINA and PPACA so they can apply these legislative provisions and be aware of their limitations in their clinical practice of breast cancer patients, in order to effectively advocate for these patients and their families.

Siebert DC. Genetics and disease prevention: complementary or contradictory? J Nurs Pract. 2010;6(7):507–16.CrossRef

2.•

Cancer Facts & Figures, 2015. American Cancer Society, Inc. Retrieved from www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf. This article is important as it provides information about incidence and current modifiable and nonmodifiable risk factors that contribute to the development of breast cancer.

3.•

Invasive Cancer Incidence-United States. 2010. Morbidity and mortality weekly report. March 28, 2014. 63(12): 253-259. This article is important as it provides current statistics for invasive breast cancer incidence in the USA, published by the Center for Surveillance, Epidemiology and Laboratory Services, from the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services.

Norrgard K. Protecting your genetic identity: GINA and HIPAA. Nat Educ. 2008;1(1):21.

Robertson JA. The $1000 genome: ethical and legal issues in whole genome sequencing of individuals. InFocus. 2003;3(3):W35–42.

Lea D. Genetic and genomic healthcare: ethical issues of importance to nurses. Online J Issues Nurs. 2008; 13(1): Manuscript 4.

National Human Genome Research Institute. Genetic information nondiscrimination act of 2008. Retrieved from http://www.genome.gov/10002328.

Rothstein MA. Current in contemporary ethics: is GINA worth the wait? J Law, Med Ethics, Relig Cult East West Perspect Bioethics. Spring 2008: 174-178.

Genetics & Public Policy Center. The genetic information nondiscrimination act. 2008. Retrieved from http://www.DNApolicy.org.

10.

United States Department of Labor. The genetic information nondiscrimination act of 2008 (GINA). September, 2009. Retrieved from http://www.dol.gov/ebsa/newsroom/fsGINA.html.

11.•

Kaiser Family Foundation. Preventive services covered by private health plans under the affordable care act. October 28, 2014. Retrieved from http://kff.org/health-reform/fact-sheet/preventive-services-covered-by-private-health-plans/. This article is important as the Kaiser Family Foundation is a trusted source of non-biased health information with no vested interests giving factual information derived from PPACA and analyzes its impact on health care from the perspective of policy experts.

12.

McMorrow S. Will the patient protection and affordable care act of 2010 improve health outcomes for individuals and families? Timely analysis of immediate health policy issues. 2010. Retrieved from http://www.urban.org/UploadedPDF/412127-2010-health-outcome.pdf.

13.

Vann JCJ. Slipping through the cracks of the breast and cervical cancer prevention and treatment act of 2000—a tragic case of failed access to care. J Nurs Law. 2011;13(3 & 4):96–106.CrossRef

14.•

Walcott FL, Dunn BK, DeShields J, Baquet C. The affordable care act and genetic testing for inheritable cancer syndromes: impact on high-risk underserved minorities. J Health Care Poor Underserved. February, 2014; 46-62. This article is important as it addresses the limitation in PPACA’ s provisions for men at risk of developing breast cancer as well as provisions for other cancer patients, other inheritable cancer syndromes associated with breast cancer and risk-reducing interventions for breast cancer not covered under PPACA.

15.

Feldman EA. The genetic information nondiscrimination act (GINA): public policy and medical practice in the age of personalized medicine. J Gen Intern Med. 2011;27(6):743–6.CrossRef

16.

Bard JS. When public health and genetic privacy collide: positive and normative theories explaining how ACA’s expansion of corporate wellness programs conflicts with GINA’s privacy rules. J Law Med Ethics. 2011;39(3):469–87.PubMed

17.

Laedtke A, O’Neill S, Rubinstein W, Vogel K. Family physicians’ awareness and knowledge of the genetic information non-discrimination act (GINA). J Genet Couns. 2011;21(2):345–52. doi:10.1007/s10897-011-9405-6.CrossRefPubMed

18.

Qureshi O, Warda Al, Rahaghi NF, Ferrer G, Ramirez J, Oliveira E, Rahaghi F. Physician’s views on targeted alpha-1 antitrypsin testing by respiratory therapists in PFT labs and their awareness of protections offered by the genetic information nondiscrimination act (GINA). Chest. 2013; 138 (4_MeetingAbstracts):456A. doi:10.1378/chest.10400.

19.

National Coalition for Health Professional Education in Genetics (NCHPEG) Core Competencies for All Health Professionals. 2007. Retrieved from http://www.nchpeg.org/index.

Titel: The Genetic Information Nondiscrimination Act of 2008 (GINA) and the Patient Protection and Affordable Care Act of 2010 (PPACA): What They Mean for Breast Cancer Patients and Their Families
verfasst von: Mary Beth Wilson Steck
Publikationsdatum: 01.06.2015
Verlag: Springer US
Erschienen in: Current Breast Cancer Reports / Ausgabe 2/2015
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI: https://doi.org/10.1007/s12609-015-0182-3

Springer Medizin

The Genetic Information Nondiscrimination Act of 2008 (GINA) and the Patient Protection and Affordable Care Act of 2010 (PPACA): What They Mean for Breast Cancer Patients and Their Families

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie